FDA Cites Pfizer Subsidiary for Lax Oversight, Quality Failures

Washington Drug Letter
A A
Pfizer subsidiary Meridian Medical Technologies is under continued pressure from the FDA to improve oversight and quality at its Missouri plants.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $120.00